The University of Chicago Header Logo

Connection

Robert Wollmann to Neuromuscular Junction

This is a "connection" page, showing publications Robert Wollmann has written about Neuromuscular Junction.
Connection Strength

1.338
  1. Rapsyn mutations in myasthenic syndrome due to impaired receptor clustering. Muscle Nerve. 2003 Sep; 28(3):293-301.
    View in: PubMed
    Score: 0.217
  2. Slow-channel transgenic mice: a model of postsynaptic organellar degeneration at the neuromuscular junction. J Neurosci. 1997 Jun 01; 17(11):4170-9.
    View in: PubMed
    Score: 0.141
  3. Exome sequencing detection of two untranslated GFPT1 mutations in a family with limb-girdle myasthenia. Clin Genet. 2014 Feb; 85(2):166-71.
    View in: PubMed
    Score: 0.105
  4. Synaptic basal lamina-associated congenital myasthenic syndromes. Ann N Y Acad Sci. 2012 Dec; 1275:36-48.
    View in: PubMed
    Score: 0.103
  5. Acute severe animal model of anti-muscle-specific kinase myasthenia: combined postsynaptic and presynaptic changes. Arch Neurol. 2012 Apr; 69(4):453-60.
    View in: PubMed
    Score: 0.096
  6. Inflammation at the neuromuscular junction in myasthenia gravis. Neurology. 1991 Sep; 41(9):1497-504.
    View in: PubMed
    Score: 0.094
  7. Congenital myasthenic syndrome associated with epidermolysis bullosa caused by homozygous mutations in PLEC1 and CHRNE. Clin Genet. 2011 Nov; 80(5):444-51.
    View in: PubMed
    Score: 0.090
  8. Mutations in MUSK causing congenital myasthenic syndrome impair MuSK-Dok-7 interaction. Hum Mol Genet. 2010 Jun 15; 19(12):2370-9.
    View in: PubMed
    Score: 0.086
  9. Mutations in LAMB2 causing a severe form of synaptic congenital myasthenic syndrome. J Med Genet. 2009 Mar; 46(3):203-8.
    View in: PubMed
    Score: 0.079
  10. Calpain activation impairs neuromuscular transmission in a mouse model of the slow-channel myasthenic syndrome. J Clin Invest. 2007 Oct; 117(10):2903-12.
    View in: PubMed
    Score: 0.072
  11. Refractoriness to a second episode of experimental myasthenia gravis. Correlation with AChR concentration and morphologic appearance of the postsynaptic membrane. J Immunol. 1987 May 15; 138(10):3269-75.
    View in: PubMed
    Score: 0.070
  12. Presynaptic congenital myasthenic syndrome due to quantal release deficiency. Neurology. 2001 Jul 24; 57(2):279-89.
    View in: PubMed
    Score: 0.047
  13. Desensitization of mutant acetylcholine receptors in transgenic mice reduces the amplitude of neuromuscular synaptic currents. Synapse. 1997 Dec; 27(4):367-77.
    View in: PubMed
    Score: 0.036
  14. Function and ultrastructure of the neuromuscular junction in post-polio syndrome. Ann N Y Acad Sci. 1995 May 25; 753:129-37.
    View in: PubMed
    Score: 0.031
  15. LG2 agrin mutation causing severe congenital myasthenic syndrome mimics functional characteristics of non-neural (z-) agrin. Hum Genet. 2012 Jul; 131(7):1123-35.
    View in: PubMed
    Score: 0.024
  16. Presynaptic failure of neuromuscular transmission and synaptic remodeling in EA2. Neurology. 2003 Dec 23; 61(12):1743-8.
    View in: PubMed
    Score: 0.014
  17. Active calcium accumulation underlies severe weakness in a panel of mice with slow-channel syndrome. J Neurosci. 2002 Aug 01; 22(15):6447-57.
    View in: PubMed
    Score: 0.013
  18. Genetic manipulation of AChR responses suggests multiple causes of weakness in slow-channel syndrome. Ann N Y Acad Sci. 1998 May 13; 841:167-80.
    View in: PubMed
    Score: 0.009
  19. Effector mechanisms of myasthenic antibodies. Ann N Y Acad Sci. 1993 Jun 21; 681:264-73.
    View in: PubMed
    Score: 0.007
  20. Induction of the morphologic changes of both acute and chronic experimental myasthenia by monoclonal antibody directed against acetylcholine receptor. Acta Neuropathol. 1984; 63(2):131-43.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.